Search for Clinical Trial Results

Sponsored By

Pulmonary Eosinophilia - 20 Studies Found

Status Study
Completed Study Name: A Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
Condition: Eosinophilic Asthma
Date: 2011-01-25
Interventions:
  • Drug: Reslizumab Patients were
Completed Study Name: A Study to Evaluate the Efficacy and Safety of Reslizumab (0.3 or 3.0 mg/kg) as Treatment for Patients (12-75 Years of Age) With Eosinophilic Asthma
Condition: Eosinophilic Asthma
Date: 2010-12-29
Interventions:
  • Drug: Reslizumab 3.0 mg/kg or

Terminated Study Name: Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of Reslizumab (3.0 mg/kg) as Treatment for Patients (12 Through 75 Years of Age) With Eosinophilic Asthma
Condition: Eosinophilic Asthma
Date: 2011-02-04
Interventions: Drug: Reslizumab Reslizumab (3.0 mg/kg) administered intravenously by infusion every 28 days (±7 da
Completed Study Name: A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophilic Asthma
Condition: Eosinophilic Asthma
Date: 2011-01-28
Interventions:
  • Drug: Reslizumab Patients were
Completed Study Name: A Phase IIa Study of KHK4563
Condition: Uncontrolled and Suspected Eosinophilic Asthma
Date: 2011-08-07
Interventions:
  • Drug: KHK4563 every 4 weeks fo
Completed Study Name: Effect of OC000459 on Eosinophilic Airway Inflammation in Severe Asthma
Condition: Severe Eosinophilic Asthma
Date: 2015-09-04
Interventions:
  • Drug: OC000459
  • Drug: Placebo
Completed Study Name: Study to Evaluate the Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
Condition: Eosinophilic Asthma
Date: 2012-01-03
Interventions:
  • Drug: Reslizumab Reslizumab ad
Active, not recruiting Study Name: Effects of Mepolizumab Compared to Placebo on Airway Physiology in Patients With Eosinophilic Asthma: MEMORY Study
Condition: Asthma
Date: 2015-08-31
Interventions:
  • Drug: Mepolizumab 100 mg SC ev
Completed Study Name: Cessation Versus Continuation of Long-term Mepolizumab in Severe Eosinophilic Asthma Patients
Condition: Asthma
Date: 2015-09-17
Interventions:
  • Biological: Mepolizumab 100mg

Completed Study Name: Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control
Condition: Asthma
Date: 2014-10-30
Interventions:
  • Biological: Mepolizumab Humani
Next >>>